chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Hot flush, Hyperhidrosis, Malaise, Myalgia
Clinical narrative: CHILLS; MUSCLE ACHES; SWEATING; FEVER; HOT FLASHES; STOMACH PAINS; DIARRHEA; HEADACHES; EXTREME WEAKNESS AND FATIGUE; UNABLE TO DO ANYTHING AT ALL EXCEPT STAY IN BED ALL DAY; BODY ACHES; COULD BARELY EAT ANYTHING EXCEPT DRINK WATER AND SOUPS; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of CHILLS (CHILLS), MYALGIA (MUSCLE ACHES), HYPERHIDROSIS (SWEATING), PYREXIA (FEVER) and HOT FLUSH (HOT FLASHES) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (no medical history provided).    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHILLS (CHILLS), MYALGIA (MUSCLE ACHES), HYPERHIDROSIS (SWEATING), PYREXIA (FEVER), HOT FLUSH (HOT FLASHES), ABDOMINAL PAIN UPPER (STOMACH PAINS), DIARRHOEA (DIARRHEA), HEADACHE (HEADACHES), ASTHENIA (EXTREME WEAKNESS AND FATIGUE), MALAISE (UNABLE TO DO ANYTHING AT ALL EXCEPT STAY IN BED ALL DAY), PAIN (BODY ACHES) and DECREASED APPETITE (COULD BARELY EAT ANYTHING EXCEPT DRINK WATER AND SOUPS). The patient was treated with PARACETAMOL (TYLENOL) for Pain, at an unspecified dose and frequency. At the time of the report, CHILLS (CHILLS), MYALGIA (MUSCLE ACHES), HYPERHIDROSIS (SWEATING), PYREXIA (FEVER), HOT FLUSH (HOT FLASHES), ABDOMINAL PAIN UPPER (STOMACH PAINS), DIARRHOEA (DIARRHEA), HEADACHE (HEADACHES), ASTHENIA (EXTREME WEAKNESS AND FATIGUE), MALAISE (UNABLE TO DO ANYTHING AT ALL EXCEPT STAY IN BED ALL DAY), PAIN (BODY ACHES) and DECREASED APPETITE (COULD BARELY EAT ANYTHING EXCEPT DRINK WATER AND SOUPS) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       no concomitant medication provided patient felling better after taking treatment
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: CHILLS; MUSCLE ACHES; SWEATING; FEVER; HOT FLASHES; STOMACH PAINS; DIARRHEA; HEADACHES; EXTREME WEAKNESS AND FATIGUE; UNABLE TO DO ANYTHING AT ALL EXCEPT STAY IN BED ALL DAY; BODY ACHES; COULD BARELY EAT ANYTHING EXCEPT DRINK WATER AND SOUPS; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of CHILLS (CHILLS), MYALGIA (MUSCLE ACHES), HYPERHIDROSIS (SWEATING), PYREXIA (FEVER) and HOT FLUSH (HOT FLASHES) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (no medical history provided).    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHILLS (CHILLS), MYALGIA (MUSCLE ACHES), HYPERHIDROSIS (SWEATING), PYREXIA (FEVER), HOT FLUSH (HOT FLASHES), ABDOMINAL PAIN UPPER (STOMACH PAINS), DIARRHOEA (DIARRHEA), HEADACHE (HEADACHES), ASTHENIA (EXTREME WEAKNESS AND FATIGUE), MALAISE (UNABLE TO DO ANYTHING AT ALL EXCEPT STAY IN BED ALL DAY), PAIN (BODY ACHES) and DECREASED APPETITE (COULD BARELY EAT ANYTHING EXCEPT DRINK WATER AND SOUPS). The patient was treated with PARACETAMOL (TYLENOL) for Pain, at an unspecified dose and frequency. At the time of the report, CHILLS (CHILLS), MYALGIA (MUSCLE ACHES), HYPERHIDROSIS (SWEATING), PYREXIA (FEVER), HOT FLUSH (HOT FLASHES), ABDOMINAL PAIN UPPER (STOMACH PAINS), DIARRHOEA (DIARRHEA), HEADACHE (HEADACHES), ASTHENIA (EXTREME WEAKNESS AND FATIGUE), MALAISE (UNABLE TO DO ANYTHING AT ALL EXCEPT STAY IN BED ALL DAY), PAIN (BODY ACHES) and DECREASED APPETITE (COULD BARELY EAT ANYTHING EXCEPT DRINK WATER AND SOUPS) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       no concomitant medication provided patient felling better after taking treatment
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Chills, Eating disorder, Fatigue, Nausea
Clinical narrative: Chills; Extreme Fatigue; Neuropathic pain that moves around; Stomach also became upset; Cannot eat anything without discomfort; High degree of nausea; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), FATIGUE (Extreme Fatigue), NEURALGIA (Neuropathic pain that moves around), ABDOMINAL DISCOMFORT (Stomach also became upset) and EATING DISORDER (Cannot eat anything without discomfort) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (NO medical history).    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced CHILLS (Chills), FATIGUE (Extreme Fatigue), NEURALGIA (Neuropathic pain that moves around), ABDOMINAL DISCOMFORT (Stomach also became upset), EATING DISORDER (Cannot eat anything without discomfort) and NAUSEA (High degree of nausea). At the time of the report, CHILLS (Chills), FATIGUE (Extreme Fatigue), NEURALGIA (Neuropathic pain that moves around), ABDOMINAL DISCOMFORT (Stomach also became upset), EATING DISORDER (Cannot eat anything without discomfort) and NAUSEA (High degree of nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       no concomitant medication and treatment provided
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Neuralgia
Clinical narrative: Chills; Extreme Fatigue; Neuropathic pain that moves around; Stomach also became upset; Cannot eat anything without discomfort; High degree of nausea; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), FATIGUE (Extreme Fatigue), NEURALGIA (Neuropathic pain that moves around), ABDOMINAL DISCOMFORT (Stomach also became upset) and EATING DISORDER (Cannot eat anything without discomfort) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (NO medical history).    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced CHILLS (Chills), FATIGUE (Extreme Fatigue), NEURALGIA (Neuropathic pain that moves around), ABDOMINAL DISCOMFORT (Stomach also became upset), EATING DISORDER (Cannot eat anything without discomfort) and NAUSEA (High degree of nausea). At the time of the report, CHILLS (Chills), FATIGUE (Extreme Fatigue), NEURALGIA (Neuropathic pain that moves around), ABDOMINAL DISCOMFORT (Stomach also became upset), EATING DISORDER (Cannot eat anything without discomfort) and NAUSEA (High degree of nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       no concomitant medication and treatment provided
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper
Clinical narrative: bad cramping for 5 days then it stopped; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (bad cramping for 5 days then it stopped) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for an unknown indication.    The patient's past medical history included No adverse event (no medical history provided).   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) (unknown route) at an unspecified dose. On an unknown date, the patient experienced ABDOMINAL PAIN UPPER (bad cramping for 5 days then it stopped). At the time of the report, ABDOMINAL PAIN UPPER (bad cramping for 5 days then it stopped) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       no concomitant medication provided. caller refused to provide additional information
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea
Clinical narrative: harder to breathe after getting the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (harder to breathe after getting the vaccine) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M204) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history provided).    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced DYSPNOEA (harder to breathe after getting the vaccine). At the time of the report, DYSPNOEA (harder to breathe after getting the vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       no concomitant medication and treatment provided
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Chills
Clinical narrative: Chills; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills) in an 86-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     Concomitant products included MESALAZINE (LIALDA) for an unknown indication.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, the patient experienced CHILLS (Chills). At the time of the report, CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 55.0
Sex: U
Vaccine: COVID19
Symptoms: Blood pressure measurement, Epistaxis, Fatigue, Musculoskeletal stiffness
Clinical narrative: nose bleeding; fatigue; stiffness; This spontaneous case was reported by a physician and describes the occurrence of FATIGUE (fatigue) in a 55-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history provided).    On 12-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Feb-2021, the patient experienced FATIGUE (fatigue). The patient was treated with PARACETAMOL (DOLIPRANE) at an unspecified dose and frequency. At the time of the report, FATIGUE (fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Feb-2021, Blood pressure measurement: 160/110 (High) high. On 18-Feb-2021, Blood pressure measurement: 140/100 (High) high.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   no concomitant medication provided
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Eye pain, Fatigue
Clinical narrative: Eyes Ached; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of EYE PAIN (Eyes Ached) and FATIGUE (Fatigue) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History was provided by the reporter.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced EYE PAIN (Eyes Ached) and FATIGUE (Fatigue). On 04-Feb-2021, EYE PAIN (Eyes Ached) and FATIGUE (Fatigue) had resolved.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 26-Apr-2021
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Metamorphopsia, Visual impairment, Vitreous floaters
Clinical narrative: started seeing "floaters" or "prisms" in his eyes; as if he was looking through a kaleidoscope/impairment or blurred vision elapsed; vision was distorted for a little bit; This spontaneous case was reported by a consumer and describes the occurrence of VITREOUS FLOATERS (started seeing "floaters" or "prisms" in his eyes), VISUAL IMPAIRMENT (as if he was looking through a kaleidoscope/impairment or blurred vision elapsed) and METAMORPHOPSIA (vision was distorted for a little bit) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     The patient's past medical history included Seasonal asthma. Concurrent medical conditions included Penicillin allergy, Drug allergy (Cleocin), Drug allergy (Varieties blue cheese) and BPH. Concomitant products included TAMSULOSIN for BPH, FISH OIL and CHOLECALCIFEROL for Nutritional supplement, ALBUTEROL [SALBUTAMOL] and FLUTICASONE PROPIONATE;SALMETEROL for Seasonal asthma.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced VITREOUS FLOATERS (started seeing "floaters" or "prisms" in his eyes), VISUAL IMPAIRMENT (as if he was looking through a kaleidoscope/impairment or blurred vision elapsed) and METAMORPHOPSIA (vision was distorted for a little bit). On 16-Feb-2021, VITREOUS FLOATERS (started seeing "floaters" or "prisms" in his eyes), VISUAL IMPAIRMENT (as if he was looking through a kaleidoscope/impairment or blurred vision elapsed) and METAMORPHOPSIA (vision was distorted for a little bit) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.        Treatment medications were not provided by the reporter.    Most recent FOLLOW-UP information incorporated above includes: On 04-May-2021: (Follow-up received on 04-MAY-2021)  Reporter contact details updated. On 14-Jul-2021: Follow-up information was received on 14-Jul-2021. Primary reporter details were added. Facility details was added. Patient demographic was added. Historical condition was added. Concomitant medications were added.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling
Clinical narrative: Red Arm (Injection Site); Itchiness (Injection Site); Swollen (Injection Site); This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (Red Arm (Injection Site)), INJECTION SITE PRURITUS (Itchiness (Injection Site)) and INJECTION SITE SWELLING (Swollen (Injection Site)) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history provided).    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced INJECTION SITE ERYTHEMA (Red Arm (Injection Site)), INJECTION SITE PRURITUS (Itchiness (Injection Site)) and INJECTION SITE SWELLING (Swollen (Injection Site)). On 16-Feb-2021, INJECTION SITE ERYTHEMA (Red Arm (Injection Site)), INJECTION SITE PRURITUS (Itchiness (Injection Site)) and INJECTION SITE SWELLING (Swollen (Injection Site)) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       no concomitant medication and treatment provided
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: lymph node swelling, same arm as injection; This spontaneous case was reported by a consumer and describes the occurrence of   in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history provided).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       no concomitant and treatment provided   This case was linked to US-MODERNATX, INC.-MOD-2021-015627, US-MODERNATX, INC.-MOD-2021-015727 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-015627: US-MODERNATX, INC.-MOD-2021-015727:
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Myalgia, Pain, Vaccination site pain
Clinical narrative: Pain at injection site that got more acute when he went to sleep; Achy all over; Body aches; Knees hurt; Muscle Aches; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Pain at injection site that got more acute when he went to sleep), PAIN (Achy all over), MYALGIA (Body aches), ARTHRALGIA (Knees hurt) and MYALGIA (Muscle Aches) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     The patient's past medical history included COVID-19.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Feb-2021, the patient experienced VACCINATION SITE PAIN (Pain at injection site that got more acute when he went to sleep), PAIN (Achy all over), MYALGIA (Body aches), ARTHRALGIA (Knees hurt) and MYALGIA (Muscle Aches). At the time of the report, VACCINATION SITE PAIN (Pain at injection site that got more acute when he went to sleep), PAIN (Achy all over), MYALGIA (Body aches), ARTHRALGIA (Knees hurt) and MYALGIA (Muscle Aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       no concomitant medication and treatment provided patient had a covid 19 medical history in september
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Dysuria, Urinary tract infection
Clinical narrative: Pain when urinating; May have an infection - UTI; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 18-Feb-2021 and was forwarded to Moderna on 18-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of DYSURIA (Pain when urinating) and URINARY TRACT INFECTION (May have an infection - UTI) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L208) for COVID-19 vaccination.     No Medical History information was reported.   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced DYSURIA (Pain when urinating) and URINARY TRACT INFECTION (May have an infection - UTI). At the time of the report, DYSURIA (Pain when urinating) and URINARY TRACT INFECTION (May have an infection - UTI) had resolved.            Concomitant product use was not provided by the reporter.  The patient reported that she had received both the shots and was fine. Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021: Additional information received captured reporter contact details, event outcome and dosage information.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Influenza like illness, Pain, Rhinorrhoea, Vaccination site erythema
Clinical narrative: hot like fire; chills; feels like I have the flu; ached; runny nose like a faucet; red; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of CHILLS (chills) and THROAT IRRITATION (scratchy throat) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history provided). Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) and HYDROCHLOROTHIAZIDE (DIURETIC [HYDROCHLOROTHIAZIDE]) for an unknown indication.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced CHILLS (chills) and THROAT IRRITATION (scratchy throat). The patient was treated with IPRATROPIUM BROMIDE at an unspecified dose and frequency. At the time of the report, CHILLS (chills) and THROAT IRRITATION (scratchy throat) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       patient has given a pill by her pcp but she don't know the actual name of it.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: hot like fire; chills; feels like I have the flu; ached; runny nose like a faucet; red; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of CHILLS (chills) and THROAT IRRITATION (scratchy throat) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history provided). Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) and HYDROCHLOROTHIAZIDE (DIURETIC [HYDROCHLOROTHIAZIDE]) for an unknown indication.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced CHILLS (chills) and THROAT IRRITATION (scratchy throat). The patient was treated with IPRATROPIUM BROMIDE at an unspecified dose and frequency. At the time of the report, CHILLS (chills) and THROAT IRRITATION (scratchy throat) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       patient has given a pill by her pcp but she don't know the actual name of it.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Limb discomfort, Peripheral swelling, Pruritus, Urticaria
Clinical narrative: skin starting to peel at the injection site; dry at the injection site; raised welt; arm sore; arm red; arm swollen/hard; arm itchy; This spontaneous case was reported by a non-health professional and describes the occurrence of VACCINATION SITE DRYNESS (dry at the injection site) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history found).    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, the patient experienced VACCINATION SITE DRYNESS (dry at the injection site). At the time of the report, VACCINATION SITE DRYNESS (dry at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       no concomitant medication and treatment provided
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site dryness, Vaccination site exfoliation
Clinical narrative: skin starting to peel at the injection site; dry at the injection site; raised welt; arm sore; arm red; arm swollen/hard; arm itchy; This spontaneous case was reported by a non-health professional and describes the occurrence of VACCINATION SITE DRYNESS (dry at the injection site) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history found).    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, the patient experienced VACCINATION SITE DRYNESS (dry at the injection site). At the time of the report, VACCINATION SITE DRYNESS (dry at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       no concomitant medication and treatment provided
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Injection site erythema, Injection site pruritus, Injection site swelling, Peripheral swelling
Clinical narrative: left arm swelling; FEVER; FLU LIKE SYMPTOMS; itchy injection site; swollen injection site; Lump red area around the injection site; This spontaneous case was reported by a patient and describes the occurrence of PERIPHERAL SWELLING (left arm swelling), PYREXIA (FEVER), INFLUENZA LIKE ILLNESS (FLU LIKE SYMPTOMS), INJECTION SITE PRURITUS (itchy injection site) and INJECTION SITE SWELLING (swollen injection site) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (no medical history provided).   On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 15-Feb-2021, the patient experienced PERIPHERAL SWELLING (left arm swelling), PYREXIA (FEVER), INFLUENZA LIKE ILLNESS (FLU LIKE SYMPTOMS), INJECTION SITE PRURITUS (itchy injection site), INJECTION SITE SWELLING (swollen injection site) and INJECTION SITE ERYTHEMA (Lump red area around the injection site). At the time of the report, PERIPHERAL SWELLING (left arm swelling), PYREXIA (FEVER), INFLUENZA LIKE ILLNESS (FLU LIKE SYMPTOMS), INJECTION SITE PRURITUS (itchy injection site), INJECTION SITE SWELLING (swollen injection site) and INJECTION SITE ERYTHEMA (Lump red area around the injection site) outcome was unknown.            no treatment and concomitant provided   This case was linked to MOD-2021-016241 (Patient Link).
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: left arm swelling; FEVER; FLU LIKE SYMPTOMS; itchy injection site; swollen injection site; Lump red area around the injection site; This spontaneous case was reported by a patient and describes the occurrence of PERIPHERAL SWELLING (left arm swelling), PYREXIA (FEVER), INFLUENZA LIKE ILLNESS (FLU LIKE SYMPTOMS), INJECTION SITE PRURITUS (itchy injection site) and INJECTION SITE SWELLING (swollen injection site) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (no medical history provided).   On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 15-Feb-2021, the patient experienced PERIPHERAL SWELLING (left arm swelling), PYREXIA (FEVER), INFLUENZA LIKE ILLNESS (FLU LIKE SYMPTOMS), INJECTION SITE PRURITUS (itchy injection site), INJECTION SITE SWELLING (swollen injection site) and INJECTION SITE ERYTHEMA (Lump red area around the injection site). At the time of the report, PERIPHERAL SWELLING (left arm swelling), PYREXIA (FEVER), INFLUENZA LIKE ILLNESS (FLU LIKE SYMPTOMS), INJECTION SITE PRURITUS (itchy injection site), INJECTION SITE SWELLING (swollen injection site) and INJECTION SITE ERYTHEMA (Lump red area around the injection site) outcome was unknown.            no treatment and concomitant provided   This case was linked to MOD-2021-016241 (Patient Link).
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 18-Feb-2021 and was forwarded to Moderna on 18-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination.     The patient's past medical history included Sleep apnea, Hypertension, Hyperthyroidism and Pacemaker insertion (cardiac). Concurrent medical conditions included Seasonal allergy and Drug allergy (certain prostate medication (unsure)). Concomitant products included RIVAROXABAN (XARELTO), LOSARTAN, AMLODIPINE and METOPROLOL for an unknown indication.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arm). At the time of the report, PAIN IN EXTREMITY (sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.   This case was linked to MODERNATX, INC.   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: Follow up included no new information as the follow up document contains information about wife.; Sender's Comments:  MODERNATX, INC.
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Patient received the 1st dose on 11Jan2021 and on 03Feb2021 she tested positive for COVID; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (Patient received the 1st dose on 11Jan2021 and on 03Feb2021 she tested positive for COVID) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history provided).    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced SARS-COV-2 TEST POSITIVE (Patient received the 1st dose on 11Jan2021 and on 03Feb2021 she tested positive for COVID). At the time of the report, SARS-COV-2 TEST POSITIVE (Patient received the 1st dose on 11Jan2021 and on 03Feb2021 she tested positive for COVID) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Feb-2021, Sars-covid 2-antibody test: positive Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       no treatment and concomitant medication provided
Sex: U
Vaccine: COVID19
Symptoms: Lip swelling, Urticaria
Clinical narrative: hives; swollen lip; This spontaneous case was reported by a patient and describes the occurrence of URTICARIA (hives) and LIP SWELLING (swollen lip) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced URTICARIA (hives) and LIP SWELLING (swollen lip). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Swelling, at an unspecified dose and frequency. At the time of the report, URTICARIA (hives) outcome was unknown and LIP SWELLING (swollen lip) was resolving. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: injection arm red; Injection arm swollen; arm has been itching; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (arm has been itching), VACCINATION SITE ERYTHEMA (injection arm red) and VACCINATION SITE SWELLING (Injection arm swollen) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A20A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (arm has been itching). On 04-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (injection arm red) and VACCINATION SITE SWELLING (Injection arm swollen). At the time of the report, VACCINATION SITE PRURITUS (arm has been itching), VACCINATION SITE ERYTHEMA (injection arm red) and VACCINATION SITE SWELLING (Injection arm swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Chills, Dyspnoea, Pain, Pain in extremity
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Shortness of breath that might be because I'm scared), PAIN IN EXTREMITY (Arm pain), BACK PAIN (Lower back pain), PAIN (Body aches) and CHILLS (Experiencing awful chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018L20A) for COVID-19 vaccination. The patient's past medical history included COVID-19 (Patient was hospitalized with COVID in 2020.) and Pneumonia (The patient had pneumonia). On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, the patient experienced DYSPNOEA (Shortness of breath that might be because I'm scared), PAIN IN EXTREMITY (Arm pain), BACK PAIN (Lower back pain), PAIN (Body aches) and CHILLS (Experiencing awful chills). At the time of the report, DYSPNOEA (Shortness of breath that might be because I'm scared), PAIN IN EXTREMITY (Arm pain), BACK PAIN (Lower back pain), PAIN (Body aches) and CHILLS (Experiencing awful chills) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Itchiness; some pain/ Tenderness; swelling; redness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itchiness), VACCINATION SITE PAIN (some pain/ Tenderness), VACCINATION SITE SWELLING (swelling) and VACCINATION SITE ERYTHEMA (redness) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage form. On 26-Jan-2021, the patient experienced VACCINATION SITE PAIN (some pain/ Tenderness), VACCINATION SITE SWELLING (swelling) and VACCINATION SITE ERYTHEMA (redness). On 29-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Itchiness). The patient was treated with CAMPHOR, DIPHENHYDRAMINE HYDROCHLORIDE, ZINC OXIDE (BENADRYL [CAMPHOR;DIPHENHYDRAMINE HYDROCHLORIDE;ZINC OXIDE]) (topical) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PRURITUS (Itchiness), VACCINATION SITE PAIN (some pain/ Tenderness) and VACCINATION SITE ERYTHEMA (redness) had resolved and VACCINATION SITE SWELLING (swelling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 20-Apr-2021: Events pain, pruritis and erythema outcome updated to recovered/resolved.Patient denied further contact.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chills, Headache, Oropharyngeal pain, Rash
Clinical narrative: covid 19; sore throat; chills; headache; rash on  arm; This spontaneous case was reported by a physician and describes the occurrence of COVID-19 (covid 19), OROPHARYNGEAL PAIN (sore throat), RASH (rash on  arm), CHILLS (chills) and HEADACHE (headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011770A and UNK) for COVID-19 vaccination.     Concurrent medical conditions included Rheumatism (Per source, patient has a syndrome that begins with an "S" and is a form of rheumatoid arthritis.). Concomitant products included AMLODIPINE and VALACYCLOVIR [VALACICLOVIR] for an unknown indication.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Jan-2021, the patient experienced RASH (rash on  arm). On 13-Jan-2021, the patient experienced COVID-19 (covid 19), OROPHARYNGEAL PAIN (sore throat), CHILLS (chills) and HEADACHE (headache). On 13-Jan-2021, RASH (rash on  arm) had resolved. At the time of the report, COVID-19 (covid 19), OROPHARYNGEAL PAIN (sore throat), CHILLS (chills) and HEADACHE (headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Jan-2021, SARS-CoV-2 antibody test positive: positive (Positive) POSITIVE.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not reported.    This case was linked to MOD-2021-016281 (Patient Link).
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 antibody test positive
Clinical narrative: covid 19; sore throat; chills; headache; rash on  arm; This spontaneous case was reported by a physician and describes the occurrence of COVID-19 (covid 19), OROPHARYNGEAL PAIN (sore throat), RASH (rash on  arm), CHILLS (chills) and HEADACHE (headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011770A and UNK) for COVID-19 vaccination.     Concurrent medical conditions included Rheumatism (Per source, patient has a syndrome that begins with an "S" and is a form of rheumatoid arthritis.). Concomitant products included AMLODIPINE and VALACYCLOVIR [VALACICLOVIR] for an unknown indication.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Jan-2021, the patient experienced RASH (rash on  arm). On 13-Jan-2021, the patient experienced COVID-19 (covid 19), OROPHARYNGEAL PAIN (sore throat), CHILLS (chills) and HEADACHE (headache). On 13-Jan-2021, RASH (rash on  arm) had resolved. At the time of the report, COVID-19 (covid 19), OROPHARYNGEAL PAIN (sore throat), CHILLS (chills) and HEADACHE (headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Jan-2021, SARS-CoV-2 antibody test positive: positive (Positive) POSITIVE.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not reported.    This case was linked to MOD-2021-016281 (Patient Link).
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Illness, Oropharyngeal pain, Pyrexia
Clinical narrative: Sore Throat; General "sickness; Fever; Fatigue; A spontaneous report was received from a Healthcare Professional concerning a male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced fever,sore throat,fatigue and general sickness.  The patient's medical history was not reported. Concomitant medication was not reported.  on /jan-2021,Prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot/batch: unknown) for prophylaxis of COVID-19 infection.  On 01-FEB-2021, The patient experienced  fever, sore throat, fatigue and general "sickness". No laboratory details provided.  No treatment information was provided.   Action taken with mRNA-1273 in response to the events was not reported.   At the time of this report, the outcome of the events sore throat,sickness,fever,fatigue  is Unknown.
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Ageusia, Anosmia, Asthenia, COVID-19
Clinical narrative: weakness; covid-19 positive; GI upset; diarrhea; loss of taste; loss of smell; decreased appetite; This spontaneous case was reported by a health care professional and describes the occurrence of ASTHENIA (weakness), COVID-19 (covid-19 positive), ABDOMINAL DISCOMFORT (GI upset), DIARRHOEA (diarrhea) and AGEUSIA (loss of taste) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Osteoporosis. Concomitant products included CALCIUM and VITAMIN D NOS for an unknown indication.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 24-Jan-2021, the patient experienced ASTHENIA (weakness), COVID-19 (covid-19 positive), ABDOMINAL DISCOMFORT (GI upset), DIARRHOEA (diarrhea), AGEUSIA (loss of taste), ANOSMIA (loss of smell) and DECREASED APPETITE (decreased appetite). At the time of the report, ASTHENIA (weakness) had not resolved, COVID-19 (covid-19 positive) had resolved and ABDOMINAL DISCOMFORT (GI upset), DIARRHOEA (diarrhea), AGEUSIA (loss of taste), ANOSMIA (loss of smell) and DECREASED APPETITE (decreased appetite) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 24-Jan-2021, Oxygen saturation: 90 percent (Inconclusive) 90%. On 24-Jan-2021, SARS-CoV-2 antibody test: unknown (Positive) Positive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered ASTHENIA (weakness), COVID-19 (covid-19 positive), ABDOMINAL DISCOMFORT (GI upset), DIARRHOEA (diarrhea), AGEUSIA (loss of taste), ANOSMIA (loss of smell) and DECREASED APPETITE (decreased appetite) to be not related.    IV bolus fluid administration is the other treatment medication reported by reporter.   Most recent FOLLOW-UP information incorporated above includes: On 09-Jul-2021: FU received on 09-JUL-2021 -It was reported that the patient took the Pfizer vaccine, not the Moderna and had the listed side effects.
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Diarrhoea, Oxygen saturation, SARS-CoV-2 antibody test
Clinical narrative: weakness; covid-19 positive; GI upset; diarrhea; loss of taste; loss of smell; decreased appetite; This spontaneous case was reported by a health care professional and describes the occurrence of ASTHENIA (weakness), COVID-19 (covid-19 positive), ABDOMINAL DISCOMFORT (GI upset), DIARRHOEA (diarrhea) and AGEUSIA (loss of taste) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Osteoporosis. Concomitant products included CALCIUM and VITAMIN D NOS for an unknown indication.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 24-Jan-2021, the patient experienced ASTHENIA (weakness), COVID-19 (covid-19 positive), ABDOMINAL DISCOMFORT (GI upset), DIARRHOEA (diarrhea), AGEUSIA (loss of taste), ANOSMIA (loss of smell) and DECREASED APPETITE (decreased appetite). At the time of the report, ASTHENIA (weakness) had not resolved, COVID-19 (covid-19 positive) had resolved and ABDOMINAL DISCOMFORT (GI upset), DIARRHOEA (diarrhea), AGEUSIA (loss of taste), ANOSMIA (loss of smell) and DECREASED APPETITE (decreased appetite) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 24-Jan-2021, Oxygen saturation: 90 percent (Inconclusive) 90%. On 24-Jan-2021, SARS-CoV-2 antibody test: unknown (Positive) Positive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered ASTHENIA (weakness), COVID-19 (covid-19 positive), ABDOMINAL DISCOMFORT (GI upset), DIARRHOEA (diarrhea), AGEUSIA (loss of taste), ANOSMIA (loss of smell) and DECREASED APPETITE (decreased appetite) to be not related.    IV bolus fluid administration is the other treatment medication reported by reporter.   Most recent FOLLOW-UP information incorporated above includes: On 09-Jul-2021: FU received on 09-JUL-2021 -It was reported that the patient took the Pfizer vaccine, not the Moderna and had the listed side effects.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Myalgia, Nausea, Pyrexia
Clinical narrative: rash all over the body; very tired; nausea, she threw-up; body aches; running on fever 103°F; chills; This spontaneous case was reported by a patient family member or friend and describes the occurrence of PAIN (body aches), RASH (rash all over the body), PYREXIA (running on fever 103°F), CHILLS (chills) and NAUSEA (nausea, she threw-up) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (no relevant medical history provided).    On 02-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced PAIN (body aches), PYREXIA (running on fever 103°F), CHILLS (chills) and NAUSEA (nausea, she threw-up). On 03-Feb-2021, the patient experienced FATIGUE (very tired). On 04-Feb-2021, the patient experienced RASH (rash all over the body). At the time of the report, PAIN (body aches), RASH (rash all over the body), CHILLS (chills), NAUSEA (nausea, she threw-up) and FATIGUE (very tired) outcome was unknown and PYREXIA (running on fever 103°F) had not resolved.            Concomitant medications included unspecified medications for renal insufficiency and epilepsy.  It was reported that after the first dose of the vaccine, the patient was okay.